Scott Langille

Scott Langille

Keine laufenden Positionen mehr
69 Jahre
Health Technology
Consumer Services
Utilities

Profil

Scott M.
Langille
worked as Director-Corporate Finance at Biovail Corp.
Served as CFO, Director & Head-Investor Relations at Aralez Pharmaceuticals Canada, Inc. from 2011 to 2016.
Held the position of Finance Director at AltiMed Pharmaceuticals Co. and Biovail Pharmaceuticals Canada.
Worked as Chief Financial Officer at Sparta Capital Ltd., Sernova Biotherapeutics, Inc. from 2016 to 2018, Wayland Group Corp., ViRexx Medical Corp.
from 2006 to 2007, Cipher Pharmaceuticals, Inc. from 2020 to 2022, and Pure Global Cannabis, Inc. in 2020.
Held the role of Vice President at Biovail Pharmaceuticals LLC and Controller at Zimmer of Canada Ltd. Education includes undergraduate studies at Toronto Metropolitan University and an MBA from the University of Toronto.

Ehemalige bekannte Positionen von Scott Langille

UnternehmenPositionEnde
CIPHER PHARMACEUTICALS INC. Finanzdirektor/CFO 15.08.2022
PURE GLOBAL CANNABIS INC. Finanzdirektor/CFO 01.05.2020
SERNOVA BIOTHERAPEUTICS INC Finanzdirektor/CFO 04.05.2018
TRIBUTE PHARMACEUTICALS CANADA INC Finanzdirektor/CFO 01.01.2016
Finanzdirektor/CFO 01.05.2007
Sehen Sie sich die Erfahrung von Scott Langille im Detail an

Ausbildung von Scott Langille

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

7

Beziehungen ersten Grades

14

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen14

Health Technology

Health Technology

Utilities

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

AltiMed Pharmaceuticals Co.

Zimmer of Canada Ltd.

Distribution Services

Health Technology

  1. Börse
  2. Insiders
  3. Scott Langille